This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Griese M. Chronic interstitial lung disease in children. Eur Respir Rev. 2018;27(147):170100. doi:10.1183/16000617.0100-2017.GrieseMChronic interstitial lung disease in children20182714717010010.1183/16000617.0100-201729436403Open DOISearch in Google Scholar
Fan LL. Evaluation and therapy of chronic interstitial pneumonitis in children. Curr Opin Pediatr. 1994;6(3):248–54. doi:10.1097/00008480-199406000-00004.FanLLEvaluation and therapy of chronic interstitial pneumonitis in children1994632485410.1097/00008480-199406000-000048061733Open DOISearch in Google Scholar
Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol. 2004;38(5):369–78. doi:10.1002/ppul.20114.FanLLDeterdingRRLangstonCPediatric interstitial lung disease revisited20043853697810.1002/ppul.2011415376335Open DOISearch in Google Scholar
Popler J, Lesnick B, Dishop MK, Deterding RR. New coding in the international classification of diseases, ninth revision, for children's interstitial lung disease. Chest. 2012;142(3):774–80. doi:10.1378/chest.12-0492.PoplerJLesnickBDishopMKDeterdingRRNew coding in the international classification of diseases, ninth revision, for children's interstitial lung disease201214237748010.1378/chest.12-049222948581Open DOISearch in Google Scholar
Nathan N, Berdah L, Borensztajn K, Clement A. Chronic interstitial lung diseases in children: diagnosis approaches. Expert Rev Respir Med. 2018;12(12):1051–60. doi:10.1080/17476348.2018.1538795.NathanNBerdahLBorensztajnKClementAChronic interstitial lung diseases in children: diagnosis approaches2018121210516010.1080/17476348.2018.153879530345849Open DOISearch in Google Scholar
Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol. 2002;34(1):23–9. doi:10.1002/ppul.10125.DinwiddieRShariefNCrawfordOIdiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland200234123910.1002/ppul.1012512112793Open DOISearch in Google Scholar
Griese M, Haug M, Brasch F, Freihorst A, Lohse P, von Kries R, et al. Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany. Orphanet J Rare Dis. 2009;4:26. doi:10.1186/1750-1172-4-26.GrieseMHaugMBraschFFreihorstALohsePvon KriesRIncidence and classification of pediatric diffuse parenchymal lung diseases in Germany200942610.1186/1750-1172-4-26280010520003372Open DOISearch in Google Scholar
Watkin LB, Jessen B, Wiszniewski W, Vece TJ, Jan M, Sha Y, et al. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet. 2015;47(6):654–60. doi:10.1038/ng.3279.WatkinLBJessenBWiszniewskiWVeceTJJanMShaYCOPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis20154766546010.1038/ng.3279451366325894502Open DOISearch in Google Scholar
Tsui JL, Estrada OA, Deng Z, Wang KM, Law CS, Elicker BM, et al. Analysis of pulmonary features and treatment approaches in the COPA syndrome. ERJ Open Res. 2018;4(2):00017–2018. doi:10.1183/23120541.00017-2018.TsuiJLEstradaOADengZWangKMLawCSElickerBMAnalysis of pulmonary features and treatment approaches in the COPA syndrome20184200017201810.1183/23120541.00017-2018601974129977900Open DOISearch in Google Scholar
Vicary GW, Vergne Y, Santiago-Cornier A, Young LR, Roman J. Pulmonary fibrosis in hermansky-pudlak syndrome. Ann Am Thorac Soc. 2016;13(10):1839–46. doi:10.1513/AnnalsATS.201603-186FR.VicaryGWVergneYSantiago-CornierAYoungLRRomanJPulmonary fibrosis in hermansky-pudlak syndrome2016131018394610.1513/AnnalsATS.201603-186FR546615827529121Open DOISearch in Google Scholar
Balasubramanian M, Lord H, Levesque S, Guturu H, Thuriot F, Sillon G, et al. Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the ERF gene. J Med Genet. 2017;54(3):157–65. doi:10.1136/jmedgenet-2016-104143.BalasubramanianMLordHLevesqueSGuturuHThuriotFSillonGChitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the ERF gene20175431576510.1136/jmedgenet-2016-10414327738187Open DOISearch in Google Scholar
Du H, Guo Y, Ma D, Tang K, Cai D, Luo Y, et al. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita. Medicine (Baltimore). 2018;97(19):e0724. doi:10.1097/MD.0000000000010724.DuHGuoYMaDTangKCaiDLuoYA case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita20189719e072410.1097/MD.0000000000010724595942329742735Open DOISearch in Google Scholar
Savage SA. Dyskeratosis congenita. 2009 Nov 12 [Updated 2016 May 26]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2018.SavageSADyskeratosis congenita2009Nov12[Updated 2016 May 26]. In:AdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKAmemiyaAeditors.Seattle (WA)University of Washington, Seattle1993–2018.10.1016/j.hoc.2009.01.003270284719327580Search in Google Scholar
Nattes E, Lejeune S, Carsin A, Borie R, Gibertini I, Balinotti J, et al. Heterogeneity of lung disease associated with NK2 homeo-box 1 mutations. Respir Med. 2017;129:16–23. doi:10.1016/j.rmed.2017.05.014.NattesELejeuneSCarsinABorieRGibertiniIBalinottiJHeterogeneity of lung disease associated with NK2 homeo-box 1 mutations2017129162310.1016/j.rmed.2017.05.01428732825Open DOISearch in Google Scholar
Sun Y, Hu G, Luo J, Fang D, Yu Y, Wang X, et al. Mutations in methionyl-tRNA synthetase gene in a Chinese family with interstitial lung and liver disease, postnatal growth failure and anemia. J Hum Genet. 2017;62(6):647–51. doi:10.1038/jhg.2017.10.SunYHuGLuoJFangDYuYWangXMutations in methionyl-tRNA synthetase gene in a Chinese family with interstitial lung and liver disease, postnatal growth failure and anemia20176266475110.1038/jhg.2017.1028148924Open DOISearch in Google Scholar
Hadchouel A, Wieland T, Griese M, Baruffini E, Lorenz-Depiereux B, Enaud L, et al. Biallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Réunion Island. Am J Hum Genet. 2015;96(5):826–31. doi:10.1016/j.ajhg.2015.03.010.HadchouelAWielandTGrieseMBaruffiniELorenz-DepiereuxBEnaudLBiallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Réunion Island20159658263110.1016/j.ajhg.2015.03.010457027725913036Open DOISearch in Google Scholar
Xu Z, Lo WS, Beck DB, Schuch LA, Oláhová M, Kopajtich R, et al. Bi-allelic mutations in Phe-tRNA synthetase associated with a multi-system pulmonary disease support non-translational function. Am J Hum Genet. 2018;103(1):100–14. doi:10.1016/j.ajhg.2018.06.006.XuZLoWSBeckDBSchuchLAOláhováMKopajtichRBi-allelic mutations in Phe-tRNA synthetase associated with a multi-system pulmonary disease support non-translational function201810311001410.1016/j.ajhg.2018.06.006603528929979980Open DOISearch in Google Scholar
Krenke K, Szczałuba K, Bielecka T, Rydzanicz M, Lange J, Koppolu A, et al. FARSA mutations mimic phenylalanyl-tRNA synthetase deficiency caused by FARSB defects. Clin Genet. 2019;96(5):468–72. doi:10.1111/cge.13614.KrenkeKSzczałubaKBieleckaTRydzaniczMLangeJKoppoluAFARSA mutations mimic phenylalanyl-tRNA synthetase deficiency caused by FARSB defects20199654687210.1111/cge.1361431355908Open DOISearch in Google Scholar
Escobar V, Weaver DD. Aarskog syndrome. New findings and genetic analysis. JAMA. 1978;240(24):2638–41. doi:10.1001/jama.240.24.2638.EscobarVWeaverDDAarskog syndrome. New findings and genetic analysis19782402426384110.1001/jama.240.24.2638712980Open DOISearch in Google Scholar
Taveira-DaSilva AM, Markello TC, Kleiner DE, Jones AM, Groden C, Macnamara E, et al. Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features. J Med Genet. 2019;56(11):778–82. doi:10.1136/jmedgenet-2018-105560.Taveira-DaSilvaAMMarkelloTCKleinerDEJonesAMGrodenCMacnamaraEExpanding the phenotype of COPA syndrome: a kindred with typical and atypical features201956117788210.1136/jmedgenet-2018-105560686040330385646Open DOISearch in Google Scholar
Ammann S, Schulz A, Krägeloh-Mann I, Dieckmann NM, Niethammer K, Fuchs S, et al. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. Blood. 2016;127(8):997–1006. doi:10.1182/blood-2015-09-671636.AmmannSSchulzAKrägeloh-MannIDieckmannNMNiethammerKFuchsSMutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome20161278997100610.1182/blood-2015-09-671636Open DOISearch in Google Scholar
Huizing M, Malicdan MCV, Gochuico BR, Gahl WA. Hermansky-Pudlak syndrome. 2000 Jul 24 [Updated 2017 Oct 26]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019.HuizingMMalicdanMCVGochuicoBRGahlWAHermansky-Pudlak syndrome2000Jul24[Updated 2017 Oct 26]. In:AdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKeditors.Seattle (WA)University of Washington, Seattle1993–2019.Search in Google Scholar
Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med. 1998;338(18):1258–64. doi:10.1056/NEJM199804303381803.GahlWABrantlyMKaiser-KupferMIIwataFHazelwoodSShotelersukVGenetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome)19983381812586410.1056/NEJM199804303381803Open DOISearch in Google Scholar
Witkop CJ, Quevedo WC, Fitzpatrick TB, King RA. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle DL, editors. The metabolic and molecular basis of inherited disease. 6th ed. Vol 2. New York, NY: McGraw-Hill; 1989. p. 2905–47.WitkopCJQuevedoWCFitzpatrickTBKingRAAlbinismIn:ScriverCRBeaudetALSlyWSValleDLeditors.6th ed.2New York, NYMcGraw-Hill198929054710.1016/0738-081X(89)90059-XSearch in Google Scholar
Chitayat D, Haj-Chahine S, Stalker HJ, Azouz EM, Côté A, Halal F. Hyperphalangism, facial anomalies, hallux valgus, and bronchomalacia: a new syndrome? Am J Med Genet. 1993;45(1):1–4. doi:10.1002/ajmg.1320450103.ChitayatDHaj-ChahineSStalkerHJAzouzEMCôtéAHalalFHyperphalangism, facial anomalies, hallux valgus, and bronchomalacia: a new syndrome?19934511410.1002/ajmg.13204501038418638Open DOISearch in Google Scholar
Milgrom H, Stoll HL Jr, Crissey JT. Dyskeratosis congenita. A case with new features. Arch Dermatol. 1964;89:345–9. doi:10.1001/archderm.1964.01590270031007. PMID: 14096348.MilgromHStollHLJrCrisseyJTDyskeratosis congenita. A case with new features196489345910.1001/archderm.1964.01590270031007PMID: 14096348.14096348Open DOISearch in Google Scholar
Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107(7):2680–5. doi:10.1182/blood-2005-07-2622.VulliamyTJMarroneAKnightSWWalneAMasonPJDokalIMutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation200610772680510.1182/blood-2005-07-262216332973Open DOISearch in Google Scholar
Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica. 2012;97(3):353–9. doi:10.3324/haematol.2011.055269.AlterBPRosenbergPSGiriNBaerlocherGMLansdorpPMSavageSATelomere length is associated with disease severity and declines with age in dyskeratosis congenita2012973353910.3324/haematol.2011.055269329158822058220Open DOISearch in Google Scholar
Revesz T, Fletcher S, al Gazali LI, DeBuse P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet. 1992;29(9):673–5. doi:10.1136/jmg.29.9.673.ReveszTFletcherSal GazaliLIDeBusePBilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome?1992299673510.1136/jmg.29.9.67310161051404302Open DOISearch in Google Scholar
Patel NJ, Jankovic J. NKX2-1-related disorders. 2014 Feb 20 [Updated 2016 Jul 29]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2018.PatelNJJankovicJNKX2-1-related disorders2014Feb20[Updated 2016 Jul 29]. In:AdamMPArdingerHHPagonRAWallaceSEBeanLJHStephensKeditors.Seattle (WA)University of Washington, Seattle1993–2018.Search in Google Scholar
Villafuerte B, Natera-de-Benito D, González A, Mori MA, Palomares M, Nevado J, et al. The Brain-Lung-Thyroid syndrome (BLTS): a novel deletion in chromosome 14q13.2-q21.1 expands the phenotype to humoral immunodeficiency. Eur J Med Genet. 2018;61(7):393–8. doi:10.1016/j.ejmg.2018.02.007.VillafuerteBNatera-de-BenitoDGonzálezAMoriMAPalomaresMNevadoJThe Brain-Lung-Thyroid syndrome (BLTS): a novel deletion in chromosome 14q13.2-q21.1 expands the phenotype to humoral immunodeficiency2018617393810.1016/j.ejmg.2018.02.00729477862Open DOISearch in Google Scholar
Gonzalez M, McLaughlin H, Houlden H, Guo M, Yo-Tsen L, Hadjivassilious M, et al. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry. 2013;84(11):1247–9. doi:10.1136/jnnp-2013-305049.GonzalezMMcLaughlinHHouldenHGuoMYo-TsenLHadjivassiliousMExome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2201384111247910.1136/jnnp-2013-305049379603223729695Open DOISearch in Google Scholar
Hyun YS, Park HJ, Heo SH, Yoon BR, Nam SH, Kim SB, et al. Rare variants in methionyl- and tyrosyl-tRNA synthetase genes in late-onset autosomal dominant Charcot-Marie-Tooth neuropathy. Clin Genet. 2014;86(6):592–4. doi:10.1111/cge.12327.HyunYSParkHJHeoSHYoonBRNamSHKimSBRare variants in methionyl- and tyrosyl-tRNA synthetase genes in late-onset autosomal dominant Charcot-Marie-Tooth neuropathy2014866592410.1111/cge.1232724354524Open DOISearch in Google Scholar
Antonellis A, Oprescu SN, Griffin LB, Heider A, Amalfitano A, Innis JW. Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease. Hum Mutat. 2018;39(6):834–40. doi:10.1002/humu.23424.AntonellisAOprescuSNGriffinLBHeiderAAmalfitanoAInnisJWCompound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease20183968344010.1002/humu.23424599207129573043Open DOISearch in Google Scholar
Zadjali F, Al-Yahyaee A, Al-Nabhani M, Al-Mubaihsi S, Gujjar A, Raniga S, et al. Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease. Hum Mutat. 2018;39(10):1355–9. doi:10.1002/humu.23595.ZadjaliFAl-YahyaeeAAl-NabhaniMAl-MubaihsiSGujjarARanigaSHomozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease201839101355910.1002/humu.2359530014610Open DOISearch in Google Scholar
Ahmed A, Mufeed A, Ramachamparambathu AK, Hasoon U. Identifying Aarskog syndrome. J Clin Diagn Res. 2016;10(12):ZD09-11. doi:10.7860/JCDR/2016/22180.8982.AhmedAMufeedARamachamparambathuAKHasoonUIdentifying Aarskog syndrome20161012ZD09-11.10.7860/JCDR/2016/22180.8982529658628209013Open DOISearch in Google Scholar